Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs) (Seva)
Implementing a mobile-phone based system for drug use disorders in primary care settings.
Substance Use Disorders
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)|
- Implementation status [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]To measure implementation progress, we will adapt our implementation model intervention into a specific implementation plan (including timetables) for each clinic. We employ the Stages of Implementation Completion model (Chamberlain et al., 2011) to assess the degree of implementation. Each of the 8 phases of the implementation completion model is prospectively broken down into discrete tasks and events. We will assess whether each task/event was implemented and the length of time each one took to implement. Starting at the beginning of the implementation planning period (4 months before the first patient accesses Seva), the checklist will be reviewed and updated monthly by the implementation program leader, with responses verified by the clinic coach.
- Number of patients using system [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]
- Clinical adoption [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]We will analyze computerized system log files to produce metrics about patterns of system adoption by patients and staff. We will assess the characteristics of staff members (job function, years with clinic, etc.) and patients (age, gender, race, etc.) to determine individual characteristics associated with the degree of adoption.
|Study Start Date:||March 2014|
|Estimated Study Completion Date:||June 2017|
|Estimated Primary Completion Date:||June 2017 (Final data collection date for primary outcome measure)|
Up to 100 patients in each of 3 intervention clinics will receive access to the Seva mobile health system for drug use disorders.
The purpose of the research is to study the impact of a recovery support system called Seva on primary care organizations, where issues such as coordination of care, job satisfaction, and the cost of adopting and operating new technologies are critical. The study will also investigate how to best implement this kind of technology into health care delivery systems that care for people diagnosed with substance abuse.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01963234
|Contact: Fiona M McTavish, MSemail@example.com|
|Contact: Andrew R Quanbeck, Ph.D.||firstname.lastname@example.org|
|United States, Montana|
|Partnership Health Center||Recruiting|
|Missoula, Montana, United States|
|Contact: MaryJane Nealon, RN MFA|
|United States, New York|
|Institute for Family Health||Recruiting|
|Bronx, New York, United States|
|Contact: Victoria Ward|
|United States, Wisconsin|
|UW Health Access Clinic||Recruiting|
|Madison, Wisconsin, United States, 53706|
|Contact: Randall Brown, M.D. 608-333-3292|